Currently Reading
Value of Adherence
August 30, 2013
Session 2: Discussant
August 28, 2013
Session 2: Discussant
August 12, 2013
Session 1: Discussant
July 31, 2013
Session 1: Discussant
July 25, 2013
Glycemic Targeting
July 25, 2013
Therapeutic Choice and Outcomes at the Physician Level
July 23, 2013
July 19, 2013

Value of Adherence

Darius Lakdawalla, PhD
Darius Lakdawalla, PhD, addresses the value of diabetes patients' adherence in this clip.
Darius Lakdawalla, PhD, addresses the value of diabetes patients’ adherence in this clip. According to Dr Lakdawalla, diabetes patients account for about one-third of total Medicare spending. By 2050, that percentage could be one half of Medicare spending. Risk factors, including the rise of obesity in the population, are contributing to the increase of diabetes diagnoses.

To control rising costs, Dr Lakdawalla suggests interventions must be made, including biomedical innovation and technologies that can improve medication adherence. Improved adherence could be worth almost $13,000 per patient with diabetes


“Some payers have been reluctant to reimburse technologies that focus specifically on adherence and convenience and those kinds of outcomes,” says Dr Lakdawalla. “That's changing with the implementation of the ACA and other kinds of policies in which payers are taking a more holistic role in care.  Those changes, I think, are to be encouraged.”

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!